Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2006-004318-42-NL
EUCTR2006-004318-42-NL
Active, not recruiting
Not Applicable

Influence on brain perfusion and metabolism through pharmacologic agents

Department of Neurology UMCG0 sitesAugust 3, 2006
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsMultiple SclerosisMedDRA version: 8.1Level: PTClassification code 10028245Term: Multiple sclerosis
DrugsPrepulsidSpiropent

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Multiple Sclerosis
Sponsor
Department of Neurology UMCG
Status
Active, not recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 3, 2006
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Department of Neurology UMCG

Eligibility Criteria

Inclusion Criteria

  • •1\) a diagnosis of multiple sclerosis according to the McDonald criteria with a secondary progressive disease course and a disease duration of between ten and fifteen years.
  • •2\) age of eightteen years or older
  • •3\) written informed consent
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •1\) use of systemic corticosteroids in the eight weeks before the trial
  • •2\) use of immunomodulatory treatments for MS
  • •3\) a history of cerebral pathology other than MS (cerebral infarct, cerebral haemorrhages, Parkinson's disease, Alzheimer's disease, cerebral vasculitis, brain absces)
  • •4\) diabetes mellitus, cardiac arrhythmia, prolonged qt time on ecg, pregnancy or breast\-feeding.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 2
Influence on brain perfusion and metabolism through pharmacologic agentsmultiple sclerosis10012303
NL-OMON29781niversitair Medisch Centrum Groningen30
Completed
Not Applicable
Changes in cerebral blood flow and oxygenation during induction of general anesthesia with sevoflurane or propofol ;prospective randomized control trialThe patient undergoing elective operation under general anesthesia
JPRN-UMIN000013903ihon University School of Medicine20
Completed
Not Applicable
Examination of neuronal and metabolic effects of long-term transcutaneous vagus nerve stimulation in obese adult malesObesityE66
DRKS00012302niversitätsklinik zu Lübeck Medizinische Klinik 1 - Klinik für Neurologie40
Not yet recruiting
Not Applicable
Changes in cerebral blood flow due to the involvement of nurses in a remote environment in cognitive rehabilitatioDementia
JPRN-UMIN000041231Osaka Medical College10
Not yet recruiting
Not Applicable
Metabolic and neurovascular brain plasticity in amyloid-positive older people with metabolic risk factorsMetabolic risk factors defined by ATP-III-criteriaAmyloid deposition as indication of preclinical Alzheimer’s disease
DRKS00013501Deutsches Zentrum für Neurodegenerative Erkrankungen e.V.300